Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPalace Capital Regulatory News (PCA)

Share Price Information for Palace Capital (PCA)

Share Price is delayed by 15 minutes
Get Live Data
180.00    1.00 (0.56%)
Bid:
180.00
Ask:
184.00
Spread: 4.00 (2.222%)
Market Cap: £34.98m
PCA Live PriceLast checked at - London Stock Exchange

Intraday Palace Capital Share Chart

Schedule 1 - Libra Retail PLC

8 Dec 2005 10:43

AIM08 December 2005 ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH AIM RULE 2 ALL APPLICANTS MUST COMPLETE THE FOLLOWING: COMPANY NAME: Libra Retail PLC to be renamed Leo Insurance Services PLC COMPANY ADDRESS: 94-96 Great North Road, London COMPANY POSTCODE: N2 0NL COUNTRY OF INCORPORATION: England and Wales COMPANY BUSINESS OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTMENT STRATEGY TO BE DISCLOSED INACCORDANCE WITH SCHEDULE 2, PARAGRAPH (J) OF THE AIM RULES:The Company has entered into an agreement to invest in Grafton Insurance Services Limited, which is to trade as aproperty insurance broker. The Company is to be renamed Leo Insurance Services plc to reflect the change in business. DETAILS OF SECURITIES TO BE ADMITTED (i.e. where known, number of shares, nominal value and issue price to which itseeks admission and the number and type to be held as treasury shares):7,062,381 ordinary shares of 1p each fully paid CAPITAL TO BE RAISED ON ADMISSION:£202,047 FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS:Larry Glenn Lipman (Executive Chairman) Errol Alan Lipman (Executive Director) Paul Malcolm Davis (Finance Director) Edward George Young (Non-executive Director)PERSON(S) INTERESTED IN 3% OR MORE OF THE ISSUER'S CAPITAL, EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITALBEFORE AND AFTER ADMISSION: Shareholding pre % holding pre Shareholding post % holding post readmission (1) readmission readmission readmissionSafeland Holdings 2,633,926 46.87% 2,633,926 37.30%CorpSafeland plc 511,919 9.11% 511,919 7.25%Teather & Greenwood 484,961 8.63% 484,961 6.87%LimitedP O'Reilly 178,462 3.18% 178,462 2.53%Unicorn Asset - - 1,443,191 20.43%Management (1) Assumes that the 1 for 10 share consolidation has taken place NAMES AND ADDRESSES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES:None ANTICIPATED ACCOUNTING REFERENCE DATE:31 JanuaryEXPECTED ADMISSION DATE:6 January 2006NAME AND ADDRESS OF NOMINATED ADVISER:Teather & Greenwood Limited Beaufort House 15 St Botolph Street London EC3A 7QRNAME AND ADDRESS OF BROKER:Teather & Greenwood Limited Beaufort House 15 St Botolph Street London EC3A 7QRDETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENT THAT THISWILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES:Teather & Greenwood Limited Beaufort House 15 St Botolph Street London EC3A 7QRDATE OF NOTIFICATION:7 December 2005NEW/ UPDATE (see note):NEWQUOTED APPLICANTS MUST ALSO COMPLETE THE FOLLOWING: THE NAME OF THE AIM DESIGNATED MARKET UPON WHICH THE APPLICANT'S SECURITIES HAVE BEEN TRADED: THE DATE FROM WHICH THE APPLICANT'S SECURITIES HAVE BEEN SO TRADED: CONFIRMATION THAT, FOLLOWING DUE AND CAREFUL ENQUIRY, THE APPLICANT HAS ADHERED TO ANY LEGAL AND REGULATORYREQUIREMENTS INVOLVED IN HAVING ITS SECURITIES TRADED UPON SUCH A MARKET: AN ADDRESS OR WEB-SITE ADDRESS WHERE ANY DOCUMENTS OR ANNOUNCEMENTS WHICH THE APPLICANT HAS MADE PUBLIC OVER THE LASTTWO YEARS (IN CONSEQUENCE OF HAVING ITS SECURITIES SO TRADED) ARE AVAILABLE: DETAILS OF THE APPLICANT'S STRATEGY FOLLOWING ADMISSION INCLUDING, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITSINVESTMENT STRATEGY: A DESCRIPTION OF ANY SIGNIFICANT CHANGE IN FINANCIAL OR TRADING POSITION OF THE APPLICANT, WHICH HAS OCCURRED SINCE THEEND OF THE LAST FINANCIAL PERIOD FOR WHICH AUDITED STATEMENTS HAVE BEEN PUBLISHED: A STATEMENT THAT THE DIRECTORS OF THE APPLICANT HAVE NO REASON TO BELIEVE THAT THE WORKING CAPITAL AVAILABLE TO IT ORITS GROUP WILL BE INSUFFICIENT FOR AT LEAST TWELVE MONTHS FROM THE DATE OF ITS ADMISSION: DETAILS OF ANY LOCK-IN ARRANGEMENTS PURSUANT TO RULE 7 OF THE AIM RULES: A BRIEF DESCRIPTION OF THE ARRANGEMENTS FOR SETTLING THE APPLICANT'S SECURITIES: A WEBSITE ADDRESS DETAILING THE RIGHTS ATTACHING TO THE APPLICANT'S SECURITIES: INFORMATION EQUIVALENT TO THAT REQUIRED FOR AN ADMISSION DOCUMENT WHICH IS NOT CURRENTLY PUBLIC: A WEBSITE ADDRESS OF A PAGE CONTAINING THE APPLICANT'S LATEST ANNUAL REPORT AND ACCOUNTS WHICH MUST HAVE A FINANCIALYEAR END NOT MORE THEN NINE MONTHS PRIOR TO ADMISSION AND FULLY AUDITED INTERIM RESULTS WHERE APPLICABLE. THE ACCOUNTSMUST BE PREPARED ACCORDING TO UK OR US GAAP OR INTERNATIONAL ACCOUNTING STANDARDS: THE NUMBER OF EACH CLASS OF SECURITIES HELD IN TREASURY: Note: THIS FIELD SHOULD INDICATE THAT THE ANNOUNCEMENT IS 'NEW' AND ALL RELEVANTFIELDS SHOULD BE COMPLETED. OTHERWISE WHERE THE FORM IS REQUIRED TO BE COMPLETEDIN RESPECT OF AN 'UPDATE' ANNOUNCEMENT, THIS SHOULD BE INDICATED. IN SUCH CASES,ALL THE ORIGINAL INFORMATION SHOULD BE INCLUDED WITH ANY AMENDED FIELDSEMBOLDENED. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
14th Jun 20227:01 amRNSResults for the year ended 31 March 2022
14th Jun 20227:00 amRNSBoard Change
1st Jun 20225:04 pmRNSTotal Voting Rights
6th Apr 20227:00 amRNSTrading update and dividend increase
25th Mar 20229:10 amRNSHolding(s) in Company
16th Mar 20223:58 pmRNSHolding(s) in Company
15th Mar 20222:03 pmRNSHolding(s) in Company
15th Mar 20227:00 amRNSDividend Declaration and Market Update
14th Mar 20229:46 amRNSHolding(s) in Company
3rd Mar 20227:00 amRNSPalace Capital exceeds disposal strategy targets
20th Jan 20224:40 pmRNSSecond Price Monitoring Extn
20th Jan 20224:35 pmRNSPrice Monitoring Extension
17th Jan 20227:00 amRNSAcquisition of Maidenhead office building
20th Dec 20217:00 amRNSDisposal strategy nears completion
16th Dec 20217:00 amRNSAppointment of new Chairman
15th Dec 202110:46 amEQSHardman & Co Research: Hardman & Co Video | Analyst interview Q&A with Mike Foster on Palace Capital (PCA) | Interim results - ammunition for major dividend rises
9th Dec 20217:00 amRNSLetting of office space at Hudson Quarter, York
6th Dec 20217:00 amRNSSale of Staines Office Building
3rd Dec 202112:40 pmEQSHardman & Co Research : Palace Capital (PCA) - Interim results: ammunition for major dividend rises
29th Nov 20217:00 amRNSDisposal strategy continues with Aldershot sale
18th Nov 20217:00 amRNSDirector Dealing
17th Nov 20211:04 pmRNSINVESTOR PRESENTATION
16th Nov 20217:00 amRNSInterim Results
12th Nov 202110:30 amRNSHolding(s) in Company
12th Nov 20217:00 amRNSAppointment of Matthew Simpson as CFO
26th Oct 20217:00 amRNSUpdate on Chair recruitment
19th Oct 20217:00 amRNSTrading Update
4th Oct 20214:35 pmRNSPrice Monitoring Extension
30th Sep 20214:41 pmRNSSecond Price Monitoring Extn
30th Sep 20214:36 pmRNSPrice Monitoring Extension
30th Sep 20217:00 amRNSHolding(s) in Company
30th Sep 20217:00 amRNSDisposal of Holding in Circle Property Plc
20th Aug 20214:10 pmRNSDirector Dealing
13th Aug 20211:00 pmRNSDirectorate Change
29th Jul 20214:30 pmRNSResult of AGM
27th Jul 20217:00 amRNSChairman retirement & strategy update
19th Jul 20217:00 amRNSDisposal programme continues with Weybridge sale
14th Jul 20217:00 amRNSTotal Voting Rights
25th Jun 20219:00 amEQSHardman & Co Research : Hardman Talks Video | Palace Capital Management Presentation
23rd Jun 20211:45 pmRNSAnnual Report and Notice of Annual General Meeting
21st Jun 202111:30 amEQSHardman & Co Research: Palace Capital (PCA): Dividend recovery ahead of expectations
16th Jun 202110:52 amRNSDirector Dealing
9th Jun 20214:10 pmEQSHardman & Co Research : Hardman Talks Video Event | Palace Capital Management Presentation
8th Jun 20217:00 amRNSFinal Results for the year ended 31 March 2021
1st Jun 20214:03 pmRNSNotice of Results & Investor Presentation
14th May 20215:18 pmRNSDirector Declaration
22nd Apr 20214:40 pmEQSHardman & Co Research: Palace Capital (PCA): Strong trading update
14th Apr 20217:00 amRNSTrading update
19th Mar 20215:48 pmRNSDirector/PDMR Shareholding
10th Mar 20219:05 amRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.